Intervention Protocol

Subsidising artemisinin-based combination therapies supplied to the private sector: impact on use, availability, price and market share

  1. Newton Opiyo1,*,
  2. Gavin Yamey2,
  3. Paul Garner3

Editorial Group: Cochrane Effective Practice and Organisation of Care Group

Published Online: 13 JUN 2012

DOI: 10.1002/14651858.CD009926


How to Cite

Opiyo N, Yamey G, Garner P. Subsidising artemisinin-based combination therapies supplied to the private sector: impact on use, availability, price and market share (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 6. Art. No.: CD009926. DOI: 10.1002/14651858.CD009926.

Author Information

  1. 1

    Kenya Medical Research Institute/Wellcome Trust Research Programme, Child and Newborn Health Group, Nairobi, Kenya

  2. 2

    University of California, San Francisco, Global Health Group, Global Health Sciences, San Francisco, CA, USA

  3. 3

    Liverpool School of Tropical Medicine, International Health Group, Liverpool, Merseyside, UK

*Newton Opiyo, Child and Newborn Health Group, Kenya Medical Research Institute/Wellcome Trust Research Programme, PO Box 43640, Nairobi, 00100 GPO, Kenya. nopiyo@nairobi.kemri-wellcome.org.

Publication History

  1. Publication Status: New
  2. Published Online: 13 JUN 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of private sector ACT price subsidy schemes on ACT use, availability, price and market share, particularly in low-income groups.